🔎 Trials Near Me

Akèy › Kansè Endomèt › Indiana › Indianapolis

Etid klinik pou Kansè Endomèt nan Indianapolis, IN

14 etid pou Kansè Endomèt ap chèche patisipan nan sit nan ak bò kote Indianapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Ap rekriteFaz 3
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Laj 18 ak plis · Fanm · Mizajou Oct 5, 2026 · NCT07198074

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Ap rekriteFaz 2
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
  • Saint Catherine Hospital, Indianapolis
Laj 18 ak plis · Fanm · Mizajou Sep 28, 2026 · NCT05112601

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Ap rekriteFaz 2
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Laj 18 ak plis · Fanm · Mizajou Sep 24, 2026 · NCT05640999

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • Community Health Network, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Ap rekriteFaz 1
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Laj 15 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Riley Hospital for Children, Indianapolis
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Ap rekriteFaz 2
  • Ascension St. Vicent Hospital, Inc., Indianapolis
Laj 18 ak plis · Fanm · Mizajou Aug 21, 2026 · NCT05548296

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Ap rekriteFaz 1
  • Indiana University, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT07306559

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Community Health Network, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Ap rekriteFaz 3
  • Research Site, Indianapolis
Laj 18 ak plis · Fanm · Mizajou Jul 29, 2026 · NCT07044336

A Study of LY4175408 in Participants With Advanced Cancer

Ap rekriteFaz 1
  • Community Health Network, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT07046923

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Ap rekriteFaz 1/2
  • Community Health Network, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Nov 4, 2025 · NCT05902988

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Ap rekriteFaz 1/2
  • Community Health Network, Inc., Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2025 · NCT05669430

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Ap rekriteFaz 2/3
  • Indiana University, Indianapolis
Laj 18 ak plis · Fanm · Mizajou May 2, 2024 · NCT05797831

Etid Kansè Endomèt nan lòt vil

Lòt etid nan Indianapolis

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.